Drug Screening Market to Reach $29.7 Billion by 2032

Austin, Nov. 6, 2024 (GLOBE NEWSWIRE) — The S&S Insider report indicates that “The Drug screening market was valued at $7.6 billion in 2023 and is expected to reach $29.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 16.3% from 2024 to 2032.”

Increasing demand for drug testing solutions amid global drug abuse trends

Increasing cases of drug abuse worldwide have prompted governments to introduce strict regulations for reliable drug testing solutions in workplaces and other public places. It is estimated that there will be over 112,000 overdose deaths in the United States in 2023. This statistic shows how important it is to develop a trustworthy testing solution. Additionally, more than half of workplace accidents and nearly 40% of employee thefts are due to substance abuse, leading to an increasing need for screening solutions.

This allows for huge market boosters through government action; in this case, there are remedies for substance use disorders. The US Consolidated Appropriations Act 2023 allows resources to be provided to SAMHSA as additional prevention efforts even come from Canada’s Substance Use and Addiction Program. The improvements in drug testing technologies, particularly rapid systems and point-of-care technologies, are driving the expansion of markets. However, regulatory barriers often slow approval in areas with high potential.

Download a PDF example Drug Screening Market @ https://www.snsinsider.com/sample-request/4628

Main actors:

• Premier Biotech, Inc.
• Omega Laboratories, Inc.
• Psychemedics Corporation
• Labcorp
• Quest diagnosis
• Abbott
• Thermo Fisher Scientific Inc.
• Alfa Scientific Designs, Inc.
• OraSure Technologies Inc.
• ACM Global Laboratories
• CareHealth America Corp
• Sciteck, Inc.
• Siemens Healthineers AG
• F. Hoffmann-La Roche Ltd
• MPD Inc.
• Shimadzu Corporation
• Lifeloc Technologies, Inc.
• Drägerwerk AG & Co. KGaA
• Clinical Reference Laboratory, Inc.
• American Bio Medica Corporation
• Intoximeters, Inc.
• AccuSourceHR, Inc.
• Cordant healthcare solutions
• Intoxalock
• Millennium Health and others.

Drug screening market Report scope:

If you need customization Drug screening market Report, IInquire now @ https://www.snsinsider.com/enquiry/4628

Rising drug and alcohol consumption is increasing the demand for drug screening solutions

The greatest influence on the growth of the market is the increased consumption of drugs and alcohol. As the 2023 World Drug Report shows, one in seventeen people aged 15 to 64 had used drugs, with the number of users increasing to 296 million, an increase of 23%. Of all the drugs used, cannabis remains the most commonly used drug, with 219 million users worldwide. In fact, in 2022, alcohol consumption contributed to an estimated 13,524 deaths in the United States alone, further sad evidence of the real need for effective drug control solutions in the workplace and on the road.

Drug testing market growth driven by consumables and rapid testing devices

In 2023, consumables accounted for 36.2% of the drug testing market, and kits and reagents remain essential for confirmatory testing. The Office of Addiction Services and Supports has launched a system to distribute 100,000 free xylazine test strips to support harm reduction. Rapid testing devices will also see rapid growth due to increasing opioid use. According to the WHO, there are 296 million drug users worldwide, of which 60 million are opioid users. Initiatives such as the Kerala Police’s mobile SoToxa test in October 2023 are improving the rapid testing landscape. The device delivers results within five minutes.

The urine sample segment is leading the drug testing market, the oral fluid segment is developing rapidly

In 2023, urine samples dominated the drug testing market with a high share of 40.1% as many drug tests were conducted on urine. Urine drug use monitoring is important for adherence to prescribed treatments and detection of substance use, particularly in patients on opioid therapy. In addition, urine tests are also accepted by the Ministry of Health and the Ministry of Transport for both point-of-care and laboratory diagnostics. In contrast, the oral fluids market is expected to grow the fastest as oral samples provide quite effective indicators of recent drug use. Despite the challenges presented by sample integrity and quantification, advances such as specialized collection devices, for example Oral-Eze, have made oral fluid testing increasingly accurate and reliable.

The North American drug screening market is leading the way, while Asia Pacific is witnessing rapid growth

In 2023, the drug screening market was mainly dominated by North America with a share of 39.5%, with key players such as Bio-Rad Laboratories and strict local regulations regarding drug abuse leading the region. The region is also receiving attention through the efforts of San Francisco’s treatment enrollment mandate, which applies to those trying to access county funds. Alcohol consumption and increasing use of cannabis and prescription stimulants continue to drive demand for drug screening in the United States.

The Asia Pacific region is expected to be the fastest growing drug testing market, primarily due to proactive government measures to reduce drug consumption and improve testing technologies. In this region, countries such as China and Japan are improving their drug testing capabilities through the introduction of rapid testing kits and concerted efforts to provide better services. This is particularly strategic as rates of drug abuse among youth continue to rise, making the region a center for significant market growth.

Buy the full research report Drug screening market 2024-2032 @ https://www.snsinsider.com/checkout/4628

Key developments in the drug screening market

• Swedish sampling company Capitainer raised $7.7 million in Series A funding in February 2024. The funding will be used to further increase production capacity and build the distribution platform for self-collection blood collection products in both the EU and the US. This helps enable important collaborations.
• In February 2024, Veriteque entered into a distribution agreement with OraSure Technologies, making the company a leading developer of in vitro diagnostic products. Under this agreement, Veriteque will deploy OraSure’s rapid point-of-care testing for infectious diseases such as HIV, HCV and syphilis in defined areas. This would help increase access to such important, life-saving tests for healthcare providers and patients in these regions.

Table of Contents – Important Key Points

1. Introduction

1.1 Market definition

1.2 Scope (Inclusion and Exclusion)

1.3 Research assumptions

2. Summary

2.1 Market overview

2.2 Regional summary

2.3 Competition Summary

3. Research methodology

3.1 Top-down approach

3.2 Bottom-up approach

3.3. Data validation

3.4 Primary interviews

4. Impact analysis of market dynamics

4.1 Analysis of market driving factors

4.2 PESTLE analysis

4.3 Porter’s Five Forces Model

5. Statistical insights and trend reports

5.1 Trends in the adoption of drug screening methods (urine, blood, hair, saliva) by region (2023)

5.2 Scope of drug testing by region (2020-2032)

5.3 Health and professional spending on drug screening, by region, (2023)

5.4 Drug Screening Regulatory and Compliance Trends, by Region (2023)

5.5 Technology and Innovation Trends in Drug Screening Devices and Kits (2023)

6. Competitive landscape

6.1 List of major companies by region

6.2 Market share analysis by region

6.3 Product Benchmarking

6.3.1 Product specifications and features

6.3.2 Prices

6.4 Strategic initiatives

6.4.1 Marketing and Promotional Activities

6.4.2 Sales and supply chain strategies

6.4.3 Expansion plans and new product launches

6.4.4 Strategic partnerships and collaborations

6.5 Technological advances

6.6 Market positioning and branding

7. Drug Screening Market Segmentation by Product

7.1 Chapter overview

7.2 Consumables

7.3 Instruments

7.4 Rapid test devices

7.5 Services

8. Drug Screening Market Segmentation by Sample Type

8.1 Chapter overview

8.2 Urine samples

8.3 Oral fluid samples

8.4 Hair samples

8.5 Other examples

9. Drug Screening Market Segmentation by Drugs

9.1 Chapter overview

9.2 Alcohol

9.3 Cannabis/Marijuana

9.4 Cocaine

9.5 Opioids

9.6 Amphetamine and methamphetamine

9.7 LSD

9.8 Miscellaneous

10. Drug Screening Market Segmentation by End Use

10.1 Chapter overview

10.2 Drug Testing Laboratories

10.3 Workplaces

10.4 Hospitals

10.5 Miscellaneous

11. Regional analysis

12. Company Profiles

13. Use cases and best practices

14. Conclusion

Speak up Our Eexpert Analyst Ttoday too Gain Deeper IInsights @ https://www.snsinsider.com/request-analyst/4628

[For more information or need any customization research mail us at [email protected]]

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry worldwide. Our company’s goal is to provide customers with the knowledge they need to function in changing circumstances. To provide you with timely, accurate market data, consumer insights and opinions to help you make confident decisions, we use a variety of techniques including surveys, video calls and focus groups around the world.